A Randomized Phase III Study of Pembrolizumab Versus Pembrolizumab-Carboplatin- Pemetrexed for Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer with PD-L1 50% or more (LAPLACE-50): Study Protocol
Keyword(s):
Keyword(s):
Keyword(s):
2007 ◽
Vol 2
(8)
◽
pp. S306
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):